Literature DB >> 21146223

Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons.

Peter Cackett1, Ian Yeo, Chui Ming Gemmy Cheung, Eranga N Vithana, Doric Wong, Wan Ting Tay, E Shyong Tai, Tin Aung, Tien Y Wong.   

Abstract

PURPOSE: Polypoidal choroidal vasculopathy (PCV) has been described as a distinct clinical entity from choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). The present study aimed to determine risk factors for PCV and to compare associations with those for CNV secondary to AMD.
DESIGN: Case-control study. PARTICIPANTS: Patients of Chinese ethnicity with clinically and angiographically diagnosed PCV (n = 123) or CNV secondary to AMD (n = 128) were recruited from a tertiary eye hospital in Singapore. Controls without signs of PCV, CNV secondary to AMD, or other retinal pathologic features (n = 1489) were selected from a population-based study.
METHODS: Patients underwent an ophthalmologic examination including digital color fundus photography, stereoscopic fluorescein angiography (FA), and indocyanine green angiography (ICGA). Classification into PCV or CNV secondary to AMD was based on FA and ICGA findings. Risk factors were determined from a standardized interview, with blood pressure recorded using a digital automatic blood pressure monitor. MAIN OUTCOME MEASURES: Polypoidal choroidal vasculopathy or CNV secondary to AMD.
RESULTS: Persons who smoked were more likely to have PCV (39.9% vs. 13.4%) or CNV secondary to AMD (45.0% vs. 12.3%) than those who did not smoke. After controlling for age, gender, diabetes, hypercholesterolemia, and hypertension, persons who smoked were 4 times more likely to have PCV (odds ratio [OR], 4.4; 95% confidence interval [CI], 2.5-7.7; P<0.001) and CNV secondary to AMD (OR, 4.9; 95% CI, 2.7-8.8; P<0.001). A significant, negative association also was found between diastolic blood pressure and CNV secondary to AMD (OR, 0.7; 95% CI, 0.5-0.9; P = 0.017, adjusted for age, gender, smoking, diabetes, and hypercholesterolemia), but diastolic blood pressure was not associated with PCV.
CONCLUSIONS: Smoking but not other vascular risk factors is significantly associated with both PCV and CNV secondary to AMD in Chinese persons. The similarity of associations suggests that there may be common risk factors and pathological mechanisms.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146223     DOI: 10.1016/j.ophtha.2010.09.026

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  25 in total

1.  A comparison of risk factors for age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese patients.

Authors:  Xiao-Li Chen; Qin-Rui Hu; Yu-Jing Bai; Yu Deng; Hai-Wei Wang; Shan Liu; Yin-Lin Wang; Yan-Kun Yue
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-01       Impact factor: 3.117

2.  Smoking and choroidal thickness in patients over 65 with early-atrophic age-related macular degeneration and normals.

Authors:  E J Sigler; J C Randolph; J I Calzada; S Charles
Journal:  Eye (Lond)       Date:  2014-05-16       Impact factor: 3.775

3.  Iris color and associated pathological ocular complications: a review of epidemiologic studies.

Authors:  Hong-Peng Sun; Yi Lin; Chen-Wei Pan
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

Review 4.  Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.

Authors:  Yamini Sahu; Niharika Chaudhary; Mukesh Joshi; Aastha Gandhi
Journal:  Int Ophthalmol       Date:  2020-10-20       Impact factor: 2.031

5.  Association between complementary factor H Y402H polymorphisms and age-related macular degeneration in Chinese: Systematic review and meta-analysis.

Authors:  Yan-Long Quan; Ai-Yi Zhou; Zhao-Hui Feng
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

Review 6.  Aging is not a disease: distinguishing age-related macular degeneration from aging.

Authors:  Daniel Ardeljan; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2013-08-09       Impact factor: 21.198

7.  Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial.

Authors:  Adrian Koh; Timothy Y Y Lai; Kanji Takahashi; Tien Y Wong; Lee-Jen Chen; Paisan Ruamviboonsuk; Colin S Tan; Chrystel Feller; Philippe Margaron; Tock H Lim; Won Ki Lee
Journal:  JAMA Ophthalmol       Date:  2017-11-01       Impact factor: 7.389

8.  Polypoidal Choroidal Vasculopathy.

Authors:  Raquel Goldhardt; Bradley Simon Rosen
Journal:  Curr Ophthalmol Rep       Date:  2019-02-02

9.  Polypoidal Choroidal Vasculopathy.

Authors:  Joon-Bom Kim; Rajinder S Nirwan; Ajay E Kuriyan
Journal:  Curr Ophthalmol Rep       Date:  2017-04-21

10.  Carboxyethylpyrrole plasma biomarkers in age-related macular degeneration.

Authors:  Daniel Ardeljan; Jingsheng Tuo; Chi-Chao Chan
Journal:  Drugs Future       Date:  2011-09-01       Impact factor: 0.148

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.